Skip to content

Tra-Ill Dowie

Ikona (United States)

3 papers in the library · 36 citations · publishing 2023-2025

Papers

Philosophy and psychedelics: Frameworks for exceptional experience

Journal of Psychedelic Studies June 19, 2023 Tra-Ill Dowie, Julien Tempone-Wiltshire 24 citations

The book "Philosophy and Psychedelics: Frameworks for Exceptional Experience" fosters a dialogue between philosophy and psychedelic studies. It examines foundational, ontological, and epistemological questions raised by psychedelic experiences, such as the hard problem of consciousness, the metaphysical nature of the self, and the aesthetic meaning of the sublime. The work explores prevailing metaphysical frameworks, epistemic belief structures, and modes of inquiry, bringing together multiple dialectics, practices, perspectives, and methods.

Psychedelics and critical theory

Journal of Psychedelic Studies September 21, 2023 Julien Tempone-Wiltshire, Tra-Ill Dowie 10 citations

A critical response to Hauskeller's monograph argues that while his socio-political critique of psychedelic psychotherapy under neoliberalism is valuable, it underestimates how psychedelics challenge reductive biomedical models. Indigenous knowledges, combined with emerging sciences, can engage ethnomedicines less harmfully and reveal how psychedelics achieve therapeutic change through transpersonal experience. This offers a revisioning of Western psychology and cognitive science, overturning deficit models of psychopathology and expanding understanding of mind-body relations. Such an approach implicitly challenges the pharmaceutical industry and neoliberal globalization.

Understanding the Psychological Effects of Psilocybin and 3,4-Methylenedioxymethamphetamine in a Non-Clinical Population

medRxiv May 29, 2025 Paul B. Fitzgerald, Sara Webb, Nigel Christopher Denning et al. 2 citations preprint

A single dose of psilocybin, but not MDMA, produced short-term psychological changes in healthy adults: reduced neuroticism, increased extraversion, and improvements in mindfulness and connectedness one week after dosing. Psilocybin also induced stronger mystical experiences than MDMA, and the magnitude of those experiences correlated with changes in connectedness and mindfulness, though not with personality changes. Participants preferred larger group settings for MDMA than for psilocybin. The findings suggest that psilocybin's psychological effects may be mediated by mystical-type experiences.